Substantiation and Effectiveness of Remote Monitoring System Based on IoMT Using Portable ECG Device
-
Published:2024-08-16
Issue:8
Volume:11
Page:836
-
ISSN:2306-5354
-
Container-title:Bioengineering
-
language:en
-
Short-container-title:Bioengineering
Author:
Lee Hee-Young12ORCID, Kim Yoon-Ji1ORCID, Lee Kang-Hyun2ORCID, Lee Jung-Hun2, Cho Sung-Pil3ORCID, Park Junghwan3, Park Il-Hwan4, Youk Hyun14ORCID
Affiliation:
1. Digital Health Laboratory, Yonsei University Wonju College of Medicine, Wonju 26417, Gangwon State, Republic of Korea 2. Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Gangwon State, Republic of Korea 3. MEZOO Co., Ltd., Wonju 26354, Gangwon State, Republic of Korea 4. Regional Trauma Center, Wonju Severance Christian Hospital, Wonju 26426, Gangwon State, Republic of Korea
Abstract
Cardiovascular disease is a major global health concern, with early detection being critical. This study assesses the effectiveness of a portable ECG device, based on Internet of Medical Things (IoMT) technology, for remote cardiovascular monitoring during daily activities. We conducted a clinical trial involving 2000 participants who wore the HiCardi device while engaging in hiking activities. The device monitored their ECG, heart rate, respiration, and body temperature in real-time. If an abnormal signal was detected while a physician was remotely monitoring the ECG at the IoMT monitoring center, he notified the clinical research coordinator (CRC) at the empirical research site, and the CRC advised the participant to visit a hospital. Follow-up calls were made to determine compliance and outcomes. Of the 2000 participants, 318 showed abnormal signals, and 182 were advised to visit a hospital. The follow-up revealed that 139 (76.37%) responded, and 30 (21.58% of those who responded) sought further medical examination. Most visits (80.00%) occurred within one month. Diagnostic approaches included ECG (56.67%), ECG and ultrasound (20.00%), ultrasound alone (16.67%), ECG and X-ray (3.33%), and general treatment (3.33%). Seven participants (23.33% of those who visited) were diagnosed with cardiovascular disease, including conditions such as arrhythmia, atrial fibrillation, and stent requirements. The portable ECG device using the patch-type electrocardiograph detected abnormal cardiovascular signals, leading to timely diagnoses and interventions, demonstrating its potential for broad applications in preventative healthcare.
Funder
Ministry of SMEs and Startups by the Korean government Korean government Ministry of Health & Welfare, Republic of Korea
Reference33 articles.
1. Korean Law Information Center (2024, August 06). Enforcement Decree of the Medical Service Act. Ministry of Government Legislation, Available online: https://www.law.go.kr/LSW/eng/engLsSc.do?y=0&x=0&menuId=2&query=medi-cal§ion=lawNm#liBgcolor29. 2. Legal issues in telemedicine;Lee;Hanyang Law Assoc.,2021 3. Adverse Event Following Immunization Monitoring System in Japan;Okuyama;Pediatr. Infect. Dis. J.,2024 4. Chronic disease management in heart failure: Focus on telemedicine and remote monitoring;Alvarez;Rev. Cardiovasc. Med.,2021 5. Casariego-Vales, E., Blanco-López, R., Rosón-Calvo, B., Suárez-Gil, R., Santos-Guerra, F., Dobao-Feijoo, M.J., Ares-Rico, R., Bal-Alvaredo, M., and on behalf of the TELEA-COVID Lugo Comanagement Team (2021). Efficacy of telemedicine and telemonitoring in at-home monitoring of patients with COVID-19. J. Clin. Med., 10.
|
|